Insight into structure of HIV protein could aid drug design

Jun 09, 2010
A University of Iowa and University of Nebraska study has revealed the structure of an important HIV protein attached to the human protein that the virus hijacks during infection. The structural information might help researchers develop drugs that disrupt HIV replication. Image shows structure of HIV Tat protein (red) bound to human P-TEFb protein (beige and green) superimposed on artist’s rendition of HIV viruses. Credit: Tahir Tahirov, University of Nebraska Medical Center, and Narmin Tahirova, University of Nebraska at Lincoln.

Researchers at the University of Iowa Carver College of Medicine and University of Nebraska Medical Center (UNMC) have created a three-dimensional picture of an important protein that is involved in how HIV -- the virus responsible for AIDS -- is produced inside human cells. The picture may help researchers design drugs that can prevent HIV from reproducing.

The research team, led by David Price, Ph.D., UI professor of biochemistry, and Tahir Tahirov, Ph.D., professor of structural biology at the Eppley Institute at UNMC, combined expertise in protein chemistry and X-ray crystallography -- a technique for observing protein structures -- to produce the first crystal structure of the called Tat. The structure shows Tat attached to the human protein (P-TEFb) that the virus hijacks during infection.

The structure shows how Tat latches on to this particular human protein and how the interaction alters the shape of the human protein. The study is published in the June 10 issue of the journal Nature.

"We have solved the long sought-after structure of an important HIV protein," Price said. "Now that we know the details of the interaction between Tat and P-TEFb, it may be possible to design inhibitors that target P-TEFb only when it is interacting with Tat."

This distinction is important because although inhibiting P-TEFb blocks replication of the HIV virus, P-TEFb is a vital protein in human cells and inhibiting it kills cells. If an inhibitor could be designed that distinguishes between the P-TEFb attached to Tat and the form that is normal in , that drug might target without harming normal cell function.

Such compounds could be useful in combination with existing anti-HIV drugs to further reduce viral levels in HIV-infected individuals.

In addition, drugs that target P-TEFb may also be useful in treating drug-resistant HIV, which is a growing problem. The mutates very easily and can develop resistance to current drug that target viral proteins. Targeting a human protein like P-TEFb that the virus needs but cannot mutate may be a successful strategy to counter drug-resistant .

Explore further: Why are HIV survival rates lower in the Deep South than the rest of the US?

Related Stories

Selenium may slow march of AIDS

Nov 28, 2008

Increasing the production of naturally occurring proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists.

Scientists find another key to HIV success

Mar 22, 2006

Weill Cornell Medical College scientists say they've determined a protein produced by HIV infected cells prevents immune B cells from producing antibodies.

Recommended for you

Indiana HIV outbreak, hepatitis C epidemic sparks US alert

6 hours ago

Federal health officials helping to contain an HIV outbreak in Indiana state issued an alert to health departments across the U.S. on Friday, urging them to take steps to identify and track HIV and hepatitis C cases in an ...

Why are HIV survival rates lower in the Deep South than the rest of the US?

Apr 22, 2015

The Deep South region has become the epicenter of the US HIV epidemic. Despite having only 28% of the total US population, nine states in the Deep South account for nearly 40% of national HIV diagnoses. This region has the highest HIV diagnosis rates and the highest number of people living with HIV of any ...

A bad buzz: Men with HIV need fewer drinks to feel effects

Apr 20, 2015

Researchers at Yale and the VA Pittsburgh Healthcare System compared the number of drinks that men with HIV infection, versus those without it, needed to get a buzz. They found that HIV-infected men were more sensitive to ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.